Who are Meiogenix's investors?

Meiogenix's investors include Genoa Ventures, Kurma Partners, Sofinnova Partners, Casdin Capital.

How much funding has Meiogenix raised?

Meiogenix has disclosed $13M raised across 1 round.

Meiogenix

Founded 2010 · 20 employees on LinkedIn · 4 known investors

Find your way into Meiogenix

Paths you didn't know you had: your email and LinkedIn already hold routes to the Meiogenix team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Meiogenix develops a proprietary recombination technology that targets meiotic recombination to accelerate genetic gain and variety development in crops. It serves plant breeders through crop innovation partnerships and large-scale technology licensing, working on both specialty crops (tomato, fruits, vegetables) and field crops (corn, rice, wheat, soybean).

AgTech Biotech Deep Tech

Founders & leadership

Ricardo Garcia de AlbaChief Executive Officer at Meiogenix

Investors · 4

Genoa Ventureslisted by Genoa VenturesSan Francisco

How we know: Genoa Ventures's portfolio page · a partner's Signal profile · funding news · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Kurma Partnerslisted by Kurma PartnersParis · $162K – $10.8M

How we know: Kurma Partners's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Sofinnova Partnerslisted by Sofinnova PartnersParis · $540K – $27M

How we know: funding news · globenewswire.com · open dataset · 5k.vc investor directory · Not right? Tell us

Casdin CapitalreportedNew York

How we know: funding news · Not right? Tell us

Funding

SEC filings, press & company announcements

$13M disclosed across 1 round · 2021

$13MSeries ADec 2021 · 3 sources
Sofinnova Partners (lead)
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 3

Logomix Inc.Genome engineering-based drug discovery and biomanufacturing R&D support.

PhigenixPhigenix develops personalized medicine for cancer, including companion diagnostics and targeted therapies for prostate and breast cancer patients. Its work centers on early detection and targeted inhibition of PAX2 and EN2 oncogenes and a cancer vaccine using Human Beta Defensin-1 (DEFB1) mRNA to direct the immune system against cancer cells.

SEMrushSemrush provides competitive intelligence, SEO, keyword research, and content generation tools for growth marketers and small teams to improve visibility and optimize their acquisition funnel across Google and AI search.

Companies working in the same space as Meiogenix.

In the news

Meiogenix Announces $13 Million Series A Financing Round Led by Sofinnova Partnersglobenewswire.com · Dec 2021

Frequently asked questions

What does Meiogenix do?: Meiogenix develops a proprietary recombination technology that targets meiotic recombination to accelerate genetic gain and variety development in crops. It serves plant breeders through crop innovation partnerships and large-scale technology licensing, working on both specialty crops (tomato, fruits, vegetables) and field crops (corn, rice, wheat, soybean).
Who are Meiogenix's investors?: Meiogenix's investors include Genoa Ventures, Kurma Partners, Sofinnova Partners, Casdin Capital.
How much funding has Meiogenix raised?: Meiogenix has disclosed $13M raised across 1 round.